tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RVPH Stock Latest News

Reviva Pharmaceuticals Announces Public Offering Agreement
Company AnnouncementsReviva Pharmaceuticals Announces Public Offering Agreement
28d ago
8K
RVPH
Reviva Pharmaceuticals prices 20M shares at 50c in public offering
PremiumThe Fly
Reviva Pharmaceuticals prices 20M shares at 50c in public offering
28d ago
RVPH
Reviva Pharmaceuticals announces common stock, warrants offering
PremiumThe Fly
Reviva Pharmaceuticals announces common stock, warrants offering
29d ago
RVPH
Reviva Pharmaceuticals Holdings: Positive Phase 3 Data and Favorable Safety Profile Support Buy Rating
PremiumRatings
Reviva Pharmaceuticals Holdings: Positive Phase 3 Data and Favorable Safety Profile Support Buy Rating
2M ago
RVPH
Reviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia
PremiumCompany Announcements
Reviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia
2M ago
8K
RVPH
Reviva Pharmaceuticals announces full dataset for one-year Phase 3 RECOVER study
PremiumThe FlyReviva Pharmaceuticals announces full dataset for one-year Phase 3 RECOVER study
2M ago
RVPH
Reviva Pharmaceuticals Launches $50M At-Market Offering
Premium
Company Announcements
Reviva Pharmaceuticals Launches $50M At-Market Offering
2M ago
8K
RVPH
Reviva Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Reviva Pharmaceuticals Reports Q1 2025 Financial Results
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $3 from $8 at D. Boral Capital
PremiumThe Fly
Reviva Pharmaceuticals price target lowered to $3 from $8 at D. Boral Capital
2M ago
RVPH
Reviva Pharmaceuticals reports Q1 EPS (13c), consensus (18c)
PremiumThe Fly
Reviva Pharmaceuticals reports Q1 EPS (13c), consensus (18c)
2M ago
RVPH
Reviva Pharmaceuticals: Promising Schizophrenia Treatment Drives Buy Rating
PremiumRatings
Reviva Pharmaceuticals: Promising Schizophrenia Treatment Drives Buy Rating
4M ago
RVPH
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ABVC
CMPX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
APRE
BCDA
Reviva Pharmaceuticals Reports 2024 Financial Results
Premium
Company Announcements
Reviva Pharmaceuticals Reports 2024 Financial Results
4M ago
RVPH
Reviva Pharmaceuticals price target lowered to $8 from $15 at D. Boral Capital
Premium
The Fly
Reviva Pharmaceuticals price target lowered to $8 from $15 at D. Boral Capital
4M ago
RVPH
Reviva Pharmaceuticals Delays Annual Report Filing
PremiumCompany Announcements
Reviva Pharmaceuticals Delays Annual Report Filing
4M ago
RVPH
Is RVPH a Buy, Before Earnings?
PremiumPre-Earnings
Is RVPH a Buy, Before Earnings?
4M ago
RVPH
Reviva Pharmaceuticals Approves Executive Compensation Changes
PremiumCompany Announcements
Reviva Pharmaceuticals Approves Executive Compensation Changes
5M ago
8K
RVPH
Unusually active option classes on open February 12th
PremiumThe Fly
Unusually active option classes on open February 12th
5M ago
CVS
NXE
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
6M ago
ALT
EWA
Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright
Premium
The Fly
Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright
6M ago
JNJ
ITCI
Reviva Pharmaceuticals upgraded to Buy from Hold at Maxim
Premium
The Fly
Reviva Pharmaceuticals upgraded to Buy from Hold at Maxim
7M ago
RVPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >